Activation of G protein-coupled estrogen receptor induces endothelium-independent relaxation of coronary artery smooth muscle (vol 301, pg E882, 2011)

Michael E. DeBakey Institute-Division of Women's Health, Texas A & M University, College Station, Texas, 77843, USA.
AJP Endocrinology and Metabolism (Impact Factor: 4.09). 07/2011; 301(5):E882-8. DOI: 10.1152/ajpendo.00037.2011
Source: PubMed

ABSTRACT Estrogens can either relax or contract arteries via rapid, nongenomic mechanisms involving classic estrogen receptors (ER). In addition to ERα and ERβ, estrogen may also stimulate G protein-coupled estrogen receptor 1 (GPER) in nonvascular tissue; however, a potential role for GPER in coronary arteries is unclear. The purpose of this study was to determine how GPER activity influenced coronary artery reactivity. In vitro isometric force recordings were performed on endothelium-denuded porcine arteries. These studies were augmented by RT-PCR and single-cell patch-clamp experiments. RT-PCR and immunoblot studies confirmed expression of GPER mRNA and protein, respectively, in smooth muscle from either porcine or human coronary arteries. G-1, a selective GPER agonist, produced a concentration-dependent relaxation of endothelium-denuded porcine coronary arteries in vitro. This response was attenuated by G15, a GPER-selective antagonist, or by inhibiting large-conductance calcium-activated potassium (BK(Ca)) channels with iberiotoxin, but not by inhibiting NO signaling. Last, single-channel patch-clamp studies demonstrated that G-1 stimulates BK(Ca) channel activity in intact smooth muscle cells from either porcine or human coronary arteries but had no effect on channels isolated in excised membrane patches. In summary, GPER activation relaxes coronary artery smooth muscle by increasing potassium efflux via BK(Ca) channels and requires an intact cellular signaling mechanism. This novel action of estrogen-like compounds may help clarify some of the controversy surrounding the vascular effects of estrogens.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Estrogen interacts with vascular estrogen receptors (ERs) to produce vasodilator effects that could impact vascular resistance. However, the specific ER subtype and the downstream post-ER relaxation pathways involved particularly in resistance microvessels are unclear. We tested if ER subtypes mediate distinct changes in microvascular reactivity and [Ca2+]i via specific post-ER relaxation pathways in endothelium or vascular smooth muscle (VSM). Pressurized mesenteric microvessels from female Sprague-Dawley rats were loaded with fura-2 and the simultaneous changes in diameter and [Ca2+]i in response to the ER activators 17β-estradiol (E2) (all ERs), PPT (ERα), DPN (ERβ) and G1 (GPR30) were measured. In intact vessels preconstricted with phenylephrine (Phe), E2 and PPT caused similar relaxation and decrease in maintained [Ca2+]i, suggesting that E2-induced vasodilation largely involves ERα. DPN caused less relaxation and decreased [Ca2+]i, suggesting a smaller role of ERβ, while G1 caused minimal changes in vessel diameter and [Ca2+]i, suggesting little role of GPR30. To test the endothelium-dependent pathways, acetylcholine (ACh) caused vasodilation and decreased [Ca2+]i that were abolished by endothelium removal, partly inhibited with the NOS blocker L-NAME, and blocked with the K+ channel blockers tetraethylammonium (TEA) (non specific), or apamin (SKCa) plus TRAM-34 (IKCa), suggesting a role of EDHF-dependent activation of KCa channels. E2-, PPT-, DPN- and G1-induced vasodilation and decreased [Ca2+]i were not blocked by L-NAME, TEA, apamin+TRAM-34, or endothelium removal, suggesting an endothelium-independent mechanism. In endothelium-denuded vessels preconstricted with Phe or high KCl (51 mM), ER agonists caused relaxation and decrease in [Ca2+]i that were with E2=PPT>DPN>G1, were not inhibited by guanylate cyclase inhibitor ODQ, and showed similar relationship between decreased [Ca2+]i and vasorelaxation, supporting direct effects on Ca2+ entry in VSM. Immunohistochemistry revealed ERα, ERβ and GPR30 mainly in the vessel media and VSM. Thus in mesenteric microvessels, ER subtypes mediate distinct vasodilation and decreased [Ca2+]i (ERα>ERβ>GPR30) through endothelium-independent inhibition of Ca2+ entry mechanisms of VSM contraction. The American Society for Pharmacology and Experimental Therapeutics.
    Journal of Pharmacology and Experimental Therapeutics 02/2015; 352(2):291-304. DOI:10.1124/jpet.114.219865 · 3.86 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Gender-associated differences in the development of cardiovascular diseases have been described in humans and animals. These differences could explain the low incidence of cardiovascular disease in women in the reproductive period, such as stroke, hypertension, and atherosclerosis. The cardiovascular protection observed in females has been attributed to the beneficial effects of estrogen on endothelial function. Besides estrogen, sex hormones are able to modulate blood pressure by acting on important systems as cardiovascular, renal, and neural. They can have complementary or antagonistic actions. For example, testosterone can raise blood pressure by stimulating the renin-angiotensin-aldosterone system, whereas estrogen alone or combined with progesterone has been associated with decreased blood pressure. The effects of testosterone in the development of cardiovascular disease are contradictory. Although some researchers suggest a positive effect, others indicate negative actions of testosterone. Estrogens physiologically stimulate the release of endothelium-derived vasodilator factors and inhibit the renin-angiotensin system. Although the cardioprotective effects of estrogen are widely appreciated, little is known about the effects of progesterone, which is commonly used in hormone replacement therapy. Progesterone has both vasodilatory and vasoconstrictive effects in the vasculature, depending on the location of the vessel and the level of exposure. Nevertheless, the mechanisms through which sex hormones modulate blood pressure have not been fully elucidated. Therefore, the characterization of those could lead to a better understanding of hypertension in women and men and perhaps to improved forms of therapy.
    Hormone molecular biology and clinical investigation 05/2014; 18(2):89-103. DOI:10.1515/hmbci-2013-0048
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Aldosterone promotes non-genomic effects in endothelial and vascular smooth muscle cells via activation of mineralocorticoid receptors (MR) and G protein-coupled estrogen receptors (GPER). GPER activation is associated with beneficial/protective effects in the vasculature. Considering that vascular dysfunction plays a major role in diabetes-associated complications, we hypothesized that the beneficial effects mediated by vascular GPER activation, in response to aldosterone, are decreased in diabetes. Mesenteric resistance arteries from female, 14-16 weeks-old, control and diabetic (db/db) mice were used. Phenylephrine (PhE)-induced contractions were greater in arteries from db/db vs. control mice. Aldosterone (10 nM) increased maximal contractile responses to PhE in arteries from control mice, an effect elicited via activation of GPER. Although aldosterone did not increase PhE responses in arteries from db/db mice, blockade of GPER, and MR decreased PhE-induced contractile responses in db/db mesenteric arteries. Aldosterone also reduced the potency of acetylcholine (ACh)-induced relaxation in arteries from both control and db/db mice via MR-dependent mechanisms. GPER antagonism further decreased ACh-induced relaxation in the control group, but did not affect ACh responses in the diabetic group. Aldosterone increased extracellular signal-regulated kinase 1/2 phosphorylation in arteries from control and db/db mice by a GPER-dependent mechanism. GPER, but not MR, gene, and protein expression, determined by RT-PCR and immunoblotting/immunofluorescence assays, respectively, were increased in arteries from db/db mice vs. control arteries. These findings indicate that aldosterone activates both vascular MR and GPER and that the beneficial effects of GPER activation are decreased in arteries from diabetic animals. Our results further elucidate the mechanisms by which aldosterone influences vascular function and contributes to vascular dysfunction in diabetes. Financial Support: FAPESP, CNPq, and CAPES, Brazil.
    Frontiers in Pharmacology 03/2015; 6:34. DOI:10.3389/fphar.2015.00034